SCHEMBL25913163

SCHEMBL25913163

CC1CN1C1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17951155 0.81 — —
SCHEMBL19965798 0.78 PIM1 (0.33) —
SCHEMBL17951427 0.75 — —
SCHEMBL22765714 0.74 — —
SCHEMBL20934998 0.74 — —
SCHEMBL23523675 0.72 — —
SCHEMBL20935042 0.70 MAP3K12 (0.31) —
SCHEMBL21919424 0.70 — —
SCHEMBL24904058 0.70 CHRM2 (0.32) —
SCHEMBL23342242 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 — — US disclosed
Send feedback